Close Menu
Home » Clinical Genomics Technologies Closes $26M Financing Round

Clinical Genomics Technologies Closes $26M Financing Round

Jun 01, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Clinical Genomics Technologies announced today that it has completed a $26 million financing round.

The company said it will use the proceeds from the financing to commercialize Colvera, its liquid biopsy test for earlier detection of recurrent colorectal cancer, and to advance Colvera for use in CRC screening.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

After Your Number

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Not Quite How It Works

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Research, But Not in Name

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

Science Finds Support for Gene Drives Depends on Species Targeted, Ability to Control Drive; More

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.

What's Popular?

In Business News

  1. In Brief This Week: Illumina, Diagnomics, Danaher, BioDiscovery, Abbott

  2. 10x Genomics Prices IPO at $39 Per Share

  3. Bio-Rad Laboratories Sues 10x Genomics Again, Alleging Patent Infringement

  4. Natera Sells Evercord Cord Blood Banking Business to CBR

  5. Oxford Nanopore Responds in Court to Pacific Biosciences Allegations of Willful Infringement

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.